Venous thromboembolism, fetal loss and preeclampsia in pregnant women with congenital thrombophilia

Clinical Laboratory

Volumn 47, Issue 3-4, 2001, Pages 155-159

  Prandoni, P ^a   Tormene, D ^a   Simioni, P ^a   Girolami, A ^a  

^a UNIVERSITY OF PADUA MEDICAL SCHOOL   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2); ANTITHROMBIN; BLOOD CLOTTING FACTOR 5; BLOOD CLOTTING FACTOR 8; FIBRINOGEN; FOLIC ACID; HEPARIN; LOW MOLECULAR WEIGHT HEPARIN; PROTEIN C; PROTEIN S; PROTHROMBIN; VON WILLEBRAND FACTOR;

ANTICOAGULANT THERAPY; ANTITHROMBIN DEFICIENCY; CONTROLLED STUDY; DRUG CHOICE; FEMALE; FETUS WASTAGE; GENE MUTATION; GENETIC POLYMORPHISM; HOMOZYGOSITY; HUMAN; INTRAUTERINE GROWTH RETARDATION; LONG TERM CARE; PREECLAMPSIA; PREGNANCY; PROTEIN C DEFICIENCY; PROTEIN S DEFICIENCY; REVIEW; SPONTANEOUS ABORTION; STILLBIRTH; THROMBOCYTOPENIA; THROMBOEMBOLISM; THROMBOPHILIA; VEIN THROMBOSIS; VITAMIN SUPPLEMENTATION;

FEMALE; FETAL DEATH; HUMANS; PRE-ECLAMPSIA; PREGNANCY; PREGNANCY COMPLICATIONS, HEMATOLOGIC; THROMBOEMBOLISM; THROMBOPHILIA; VENOUS THROMBOSIS;

EID: 0035076202     PISSN: 14336510     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (38)

1. Activated protein C sensitivity, protein C, protein S and coagulation in normal pregnancy
2. Incidence and diagnosis of deep vein thrombosis associated with pregnancy
3. Epidemiological observations of thrombo-embolic disease during pregnancy and in the puerperium in 56,022 women
4. Acute deep venous thrombosis associated with pregnancy
5. Thromboembolic disease in pregnancy
6. A prospective study of the incidence of deep-vein thrombosis within a defined urban population
7. Pregnancy in women with congenital antithrombin III deficiency: Experience of treatment with heparin and antithrombin
8. Pregnancy and congenital deficiency in antithrombin III or protein C
9. Thrombosis and pregnancy in congenital deficiencies in AT III, protein C or protein S: Study of 78 women
10. Thrombosis during pregnancy and surgery in patients with congenital deficiency of antithrombin III, protein C, protein S
11. Thrombotic risk in hereditary antithrombin III, protein C or protein S deficiency
12. Frequency of pregnancy-related venous thromboembolism in anticoagulant factor-deficient women: Implications for prophylaxis
13. Thrombosis in pregnancy: Maternal and fetal issues
14. Arg506-Gln mutation in factor V and risk of thrombosis during pregnancy
15. Pulmonary embolism and deep vein thrombosis during pregnancy or oral contraceptive use: Prevalence of factor V Leiden
16. Activated protein C resistance (FV:Q506) and pregnancy
17. Activated protein C resistance (factor V Leiden) associated with thrombosis in pregnancy
18. Risk factors for pregnancy associated venous thromboembolism
19. Prothrombin and factor V mutations in women with a history of thrombosis during pregnancy and the puerperium
20. Prothrombin 20210 G-A, MTHFR C677T mutations in women with venous thromboembolism associated with pregnancy
21. The risk of abortion and stillbirth in antithrombin, protein C, and protein S deficient women
22. Increased fetal loss in women with heritable thrombophilia
23. Second trimester pregnancy loss is associated with activated protein C resistance
24. Factor V Leiden is associated with repeated and recurrent explained fetal losses
25. Activated protein C resistance can be associated with recurrent fetal loss
26. Factor V Leiden mutation as a risk factor for recurrent pregnancy loss
27. Usefulness of screening for congenital or acquired hemostatic abnormalities in women with previous complicated pregnancies
28. Increased risk for fetal loss in carriers of the factor V Leiden mutation
29. The risk of fetal loss in family members of probands with factor V Leiden mutation
30. Case-control study of the frequency of thrombophilic disorders in couples with late fetal loss and no thrombotic antecedent - The Nimes obstetricians and haematologists study5 (NOHA5)
31. Thrombophilic polymorphisms are common in women with fetal loss without apparent cause
32. Increased frequency of genetic thrombophilia in women with complications of pregnancy
33. Underlying disorders associated with severe early-onset preeclampsia
34. Hyperhomocysteinaemia and protein S deficiency in complicated pregnancies
35. The factor V Leiden mutation may predispose women to severe pre-eclampsia
36. Factor V Leiden, C>T MTHFR polymorphism and genetic susceptibility to preeclampsia
37. Pre-eclampsia and genetic risk factors for thrombosis: A case-control study
38. Use of antithrombotic agents during pregnancy